首页 > 市场调查报告书 > 医疗设备

生技设备基因治疗学和RNAi

微阵列分析市场规模、份额及成长分析（按产品、类型、应用、最终用户和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1900650

微阵列分析市场规模、份额及成长分析（按产品、类型、应用、最终用户和地区划分）－2026-2033年产业预测

Microarray Analysis Market Size, Share, and Growth Analysis, By Product (Consumables, Instruments), By Type (DNA Microarray, Protein Microarray), By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月22日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，微阵列分析市场规模将达到 39.9 亿美元，到 2025 年将达到 43.1 亿美元，到 2033 年将达到 79.1 亿美元，在预测期（2026-2033 年）内，复合年增长率为 7.9%。

微阵列分析市场是生物技术产业中一个充满活力的领域，专注于利用高通量技术分析基因表现和遗传变异。个人化医疗需求的不断增长、基因组学研究的进步以及慢性病发病率的上升是推动该市场成长的主要因素。此市场应用广泛，包括基因表现分析、基因型鉴定、表观遗传学和生物标记发现。微阵列技术革新了基因组学和分子生物学，使研究人员能够探索广泛的基因表现模式、识别疾病相关基因并辅助药物研发。与次世代定序和生物资讯学的协同作用进一步提升了其市场潜力。儘管北美凭藉其完善的研究基础设施继续主导市场，但亚太地区对精准医疗日益增长的关注正在推动市场进一步扩张和创新。

微阵列分析市场驱动因素

推动微阵列分析市场发展的关键因素是日益增长的个人化医疗需求。个人化医疗着重根据个人独特的基因谱客製化医疗方案，从而提高治疗的准确性和有效性。微阵列分析在这一过程中至关重要，因为它能够提供丰富的基因组信息，并有助于识别与特定疾病相关的基因突变。随着全球医疗机构加速采用个人化医疗策略，对先进微阵列分析技术的需求不断增长，推动了基因研究和诊断领域的市场成长和创新。

微阵列分析市场限制因素

微阵列分析市场面临的主要挑战之一是微阵列技术及相关分析的高成本。平台、试剂和设备的成本可能非常高昂，限制了预算有限的研究机构和医疗机构的使用。此外，数据分析的复杂性和对专业知识的需求也加重了整体经济负担。这些高成本可能会阻碍资源匮乏地区对微阵列技术的广泛应用，进而抑制市场成长。为了解决这个问题，必须努力透过技术创新和更有效率的工作流程来降低成本，使其更加经济实惠，从而提高市场渗透率。

微阵列分析市场趋势

微阵列分析市场的一个显着趋势是微阵列技术与其他体学平台（例如次世代定序(NGS) 和先进的生物资讯学工具）的融合。这种融合使得研究人员能够从多方面探索生物数据，从而整体情况了解基因组、转录组和表观基因。将微阵列数据与 NGS 数据结合，能够帮助科学家更深入地了解基因表现模式和遗传变异，进而改善疾病建模并推动个人化医疗的发展。这一趋势表明，全面的分子谱分析日益重要，并推动了相关技术的创新，从而产生更丰富、更实用价值的数据，以期能更好地理解复杂的生物学现象。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Illumina, Inc.（United States）
Agilent Technologies, Inc.（United States）
Thermo Fisher Scientific, Inc.（United States）
Merck KGaA（Germany）
PerkinElmer, Inc.（United States）
Arrayit Corporation（United States）
Bio-Rad Laboratories, Inc.（United States）
GE Healthcare（United States）
Molecular Devices, LLC.（United States）
Affymetrix（United States）
Applied Microarrays, Inc.（United States）
Oxford Gene Technology（United Kingdom）
CapitalBio Corporation（China）
Macrogen, Inc.（South Korea）
LC Sciences（United States）
Scienion AG（Germany）
Arrayjet Ltd.（United Kingdom）
RayBiotech, Inc.（United States）
Genotypic Technology Pvt. Ltd.（India）
Microarrays Inc.（United States）

结论与建议

简介目录

Product Code: SQMIG35J2057

Microarray Analysis Market size was valued at USD 3.99 Billion in 2024 and is poised to grow from USD 4.31 Billion in 2025 to USD 7.91 Billion by 2033, growing at a CAGR of 7.9% during the forecast period (2026-2033).

The Microarray Analysis Market is a dynamic segment of the biotechnology industry, focused on high-throughput techniques for analyzing gene expression and genetic variations. This growth is propelled by the rising demand for personalized medicine, advancements in genomic research, and the increasing incidence of chronic diseases. The market offers diverse applications, including gene expression profiling, genotyping, epigenetics, and biomarker discovery. Microarray technologies have transformed genomics and molecular biology, allowing researchers to explore extensive gene expression patterns, identify disease-related genes, and support drug development. The synergy with next-generation sequencing and bioinformatics enhances its market potential. While North America remains a leader due to established research infrastructure, the Asia-Pacific region is emerging with a growing emphasis on precision medicine, driving further market expansion and innovation.

Top-down and bottom-up approaches were used to estimate and validate the size of the Microarray Analysis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Microarray Analysis Market Segments Analysis

Global Microarray Analysis Market is segmented by Product, Type, Application, End User and region. Based on Product, the market is segmented into Consumables, Instruments, Software and Services. Based on Type, the market is segmented into DNA Microarray, Protein Microarray and Others. Based on Application, the market is segmented into Rese arch Applications, Drug Discovery, Disease Diagnostics and Others Applications. Based on End User, the market is segmented into Research and Academic Institutes, Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Microarray Analysis Market

A significant factor propelling the Microarray Analysis market is the rising demand for personalized medicine. This approach focuses on customizing medical treatments to suit the unique genetic profiles of individuals, thereby enhancing the precision and efficacy of therapies. Microarray analysis is integral to this process, as it delivers extensive genomic insights and helps identify genetic variations linked to specific diseases. As healthcare providers increasingly adopt personalized medicine strategies globally, the need for advanced microarray analysis techniques is expanding, subsequently driving market growth and innovation in the field of genetic research and diagnostics.

Restraints in the Microarray Analysis Market

A significant challenge facing the Microarray Analysis market is the considerable expenses linked to microarray technologies and their associated analyses. The cost of platforms, reagents, and instruments can be prohibitively high, limiting access for some research institutions and healthcare facilities with constrained budgets. Moreover, the intricate nature of data analysis and the necessity for specialized knowledge also contribute to the overall financial burden. These high costs can deter widespread adoption in resource-limited environments, thus stifling market growth. To address this issue, initiatives aimed at reducing costs and enhancing affordability through technological innovations and more efficient workflows are essential for fostering greater market penetration.

Market Trends of the Microarray Analysis Market

A prominent trend in the Microarray Analysis Market is the convergence of microarray technology with other omics platforms, such as next-generation sequencing (NGS) and advanced bioinformatics tools. This integration facilitates a multi-faceted exploration of biological data, enabling researchers to gain a holistic understanding of genomic, transcriptomic, and epigenomic landscapes. By harmonizing microarray data with NGS, scientists can achieve deeper insights into gene expression patterns and genetic variations, thereby enhancing the precision of disease modeling and personalizing medical treatments. This trend underscores the growing emphasis on comprehensive molecular profiling, driving innovations that yield richer, more actionable data in the quest to unravel complex biological phenomena.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies

Global Microarray Analysis Market Size by Product & Services & CAGR (2026-2033)

Market Overview
Consumables
Instruments
Software
Services

Global Microarray Analysis Market Size by Type & CAGR (2026-2033)

Market Overview
DNA Microarray
Protein Microarray
Others

Global Microarray Analysis Market Size by Application & CAGR (2026-2033)

Market Overview
Research Applications
Drug Discovery
Disease Diagnostics
Others Applications

Global Microarray Analysis Market Size by End User & CAGR (2026-2033)

Market Overview
Research and Academic Institutes
Pharmaceutical and Biotechnology Companies
Diagnostic Laboratories
Others

Global Microarray Analysis Market Size & CAGR (2026-2033)

North America (Product & Services, Type, Application, End User)
- US
- Canada
Europe (Product & Services, Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product & Services, Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product & Services, Type, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product & Services, Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Illumina, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arrayit Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Molecular Devices, LLC. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Affymetrix (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Applied Microarrays, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oxford Gene Technology (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CapitalBio Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Macrogen, Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LC Sciences (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Scienion AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arrayjet Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RayBiotech, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genotypic Technology Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Microarrays Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments